IBD
Inflammatory Bowel Disease
search
Inflammatory Bowel Disease
, Autoimmune Bowel Disorder
See Also
Chronic Diarrhea
Ulcerative Colitis
Crohn's Disease
Microscopic Colitis
Epidemiology
Age: 10 to 40 years old
Prevalence
of Inflammatory Bowel Disease: 3.1 Million in U.S.
First degree relative with Inflammatory Bowel Disease increases risk 10 fold
More common in caucasian patients
More common in Ashkenazi Jewish descent
History
Travel
Contaminated intake
Foodborne Illness
Waterborne Illness
Immunodeficiency
risk
High risk sexual behavior
Family History
of Gastrointestinal disease
Medications in the last 6 months (e.g.
Antibiotic
s)
Symptoms
Chronic Inflammatory Diarrhea
Crohn Disease
may also cause
Secretory Diarrhea
(
Chronic Watery Diarrhea
)
Pain
Ulcerative Colitis
Lower abdominal cramps
Relieved with
Bowel Movement
Crohn's Disease
Constant pain often in right lower quadrant
Not relieved with
Bowel Movement
Stool
Blood
Grossly bloody stool (often associated with mucus or pus) in
Ulcerative Colitis
Uncommon in
Crohn Disease
Associated symptoms
Tenesmus
Rectal urgency
Constitutional symptoms (fever, weight loss, malaise)
Signs
Abdominal Mass
Ulcerative Colitis
: No abdominal mass
Crohn's Disease
: Mass often at Right lower quadrant
Gastrointestinal Tract
Affected
Ulcerative Colitis
Affects only colon
Continuous from
Rectum
Crohn's Disease
Mouth to anus potentially affected
Discontinuous, "Skip" lesions
Bowel
Tissue affected
Ulcerative Colitis
: Mucosal disease (no
Granuloma
)
Crohn's Disease
: Transmural disease (
Granuloma
s)
Associated Conditions
Extraintestinal
See
Gynecologic Manifestations of Crohn's Disease
See
Spondyloarthropathy due to Inflammatory Bowel Disease
Gene
ral
Extraintestinal findings are associated with 25% of Inflammatory Bowel Disease cases
Crohns Disease
and
Ulcerative Colitis
are associated with similar extraintestinal disorders (more common in
Crohns Disease
)
Musculoskeletal
Osteoporosis
Colitic Arthritis
Ankylosing Spondylitis
Ocular
Episcleritis
Scleritis
Uveitis
Recurrent
Iritis
Dermatologic
Digital Clubbing
Erythema Nodosum
Pyoderma Gangrenosum
Lichen Planus
Aphthous Stomatitis
Psoriasis
Hepatobiliary
Hepatic
Steatosis
Primary Sclerosing Cholangitis
Occurs in as many as 2.5 to 7.5% of
Ulcerative Colitis
patients
Progresses to
Cirrhosis
and liver failure in most patients
Cholelithiasis
Pericholangitis
Nephrolithiasis
and
Ureterolithiasis
Decreased bile secretion with secondary steatorrhea results in increased oxalate absorption and oxaluria
Dehydration
and
Metabolic Acidosis
further risks
Kidney Stone
formation
Venous Thromboembolism
(
Deep Vein Thrombosis
,
Pulmonary Embolism
)
Relative Risk
4.3
Relative Risk
15.8 during a flare (esp. hospitalization)
Multifactorial pathogenesis (increased inflammation and decreased
Fibrinolysis
, immobilization,
Dehydration
,
Corticosteroid
s)
Opportunistic Infections in
Immunocompromised
Patients
See labs below for related organisms
May be due to
Immunosuppressant
and
Biologic Agent
s used to treat Inflammatory Bowel Disease
May also be due to inflammatory bowel conditions secondary to
Immunosuppression
(e.g.
Chemotherapy
)
Biologic Agent
s (e.g.
Infliximab
) may risk
Tuberculosis
, fungal infections
Myelosuppression (
Bone Marrow
suppression) may occur with
Cyclosporine
, 6-
Mercaptopurine
and
Azathioprine
Labs
Underlying Nutrition and Disease Severity
Complete Blood Count
Iron Deficiency Anemia
is common
Comprehensive metabolic panel
Testing may also be consistent with
Dehydration
related to decreased oral intake
C-Reactive Protein
or
Erythrocyte Sedimentation Rate
Correlates with severity
Serum Protein
level
Serum Albumin
Serum
Transferrin
Serum Prealbumin
Iron
Indices
Serum Ferritin
Serum Iron
Total Iron Binding Capacity
Labs
Stool
Studies
Infectious Diarrhea Causes
(obtain in all suspected Inflammatory Bowel Disease cases and flares of known disease)
Clostridium difficile Toxin
and culture
Enteric Pathogens Nucleic Acid Test Panels
(
Stool NAT
)
Replaces
Stool Culture
and includes specific
Diarrhea
l causes (e.g. Toxigenic
Escherichia coli
)
Fecal Calprotectin
Newer test with high
Test Sensitivity
and
Test Specificity
for Inflammatory Bowel Disease
Fecal Calprotectin
<40 mcg/g and CRP <0.5 reduce Inflammatory Bowel Disease likelihood to<1%
Menees (2015) Am J Gastroenterol 110(3):444-54 [PubMed]
Additional
Stool
studies
Stool
for
Ova and Parasite
s
Giardia
Antigen
Yersinia enterocolitica
culture
Entamoeba histolytica
serologic titers
Fecal Leukocytes
Labs
Immunocompromised
Patient Evaluation
Chlamydia trachomatis
Cryptosporidium
Antigen
Neisseria gonorrhoeae
Herpes Simplex Virus
(HSV)
Cytomegalovirus
(CMV)
Isospora belli
Mycobacterium tuberculosis
Imaging
CT Abdomen and Pelvis
(or MRI
Abdomen
)
Undifferentiated Inflammatory Bowel Disease (prior to diagnosis)
Known Inflammatory Bowel Disease with complication
Small Bowel Obstruction
Sepsis
with suspected intraabdominal source
Perianal
Sepsis
Toxic Megacolon
(accordion sign, target sign)
Bowel
perforation
Intraabdominal abscess
Fistula (
Crohn Disease
)
Fibrosis (
Crohn Disease
, with homogenous bowel wall thickening)
Abdominal XRay findings (if done for other reasons)
Perforation signs (i.e. Free air in peritoneum)
Toxic Megacolon
Dilated transverse colon >6 cm (with other systemic findings)
Thumb-printing
Pattern of multiple locations where bowel wall appears indented (as if by a thumbs)
Differential Diagnosis
Gene
ral
Lower GI Bleed
ing
Diverticulitis
(most common cause)
Angiodysplasia
(
Arteriovenous Malformation
)
Neoplasm
Ulcerative Colitis
(Blood
Diarrhea
distinguishes from
Crohn's Disease
)
Ischemic Colitis
(Older patients with sudden onset pain)
Anorectal Disease
Hemorrhoid
s
Anal Fissure
s
Diarrhea
Non-Infectious
Osmotic Diarrhea
Non-Infectious
Secretory Diarrhea
Ulcerative Colitis
(bloody
Diarrhea
)
Crohn's Disease
Irritable Bowel Syndrome
(diagnosis of exclusion)
Fecal Impaction
(with leakage)
Infectious Diarrhea
(Sudden onset and often painful)
Pseudomembranous colitis
of
Clostridium difficile
(recent
Antibiotic
use)
Entamoeba histolytica
Tuberculosis
Cytomegalovirus
Yersinia
Strongyloides
Differential Diagnosis
Distinguishing
Crohn's Disease
from
Ulcerative Colitis
Location
Crohn's Disease
can involve any area of
Gastrointestinal Tract
(most common in ileocolic region)
Ulcerative Colitis
is typically limited to colon, and has onset at the
Rectum
Thickness
Crohn's Disease
involves the entire bowel wall
Ulcerative Colitis
is limited to the mucosa and submucosa
Colonoscopy
Crohn's Disease
demonstrates skip lesions, cobblestoning, ulcerations and strictures
Ulcerative Colitis
demonstrates pseudopolyps, continuous areas of inflammation
Other discriminating factors
Anemia
is more common in
Ulcerative Colitis
Abdominal Pain
is more common in
Crohn's Disease
Anorexia
and weight loss is common in
Crohn's Disease
Rectal Bleeding
is more common in
Ulcerative Colitis
(bloody
Diarrhea
is a common presentation)
Colon Cancer
is much more common in
Ulcerative Colitis
Diagnosis
Colonoscopy
with mucosal biopsy
Crohn Disease
often has a delayed diagnosis (mean 7 years of symptoms prior to correct diagnosis)
Inflammatory Bowel Disease initial diagnosis (
Crohn Disease
versus
Ulcerative Colitis
) is incorrect >80% of the time
Mitchell (2007) Tech Coloproctol 11(2): 91-6 [PubMed]
Management
See
Ulcerative Colitis
(bloody
Diarrhea
)
See
Crohn's Disease
See
Microscopic Colitis
Precautions
Consult gastroenterology in acute presentations prior to diagnosis and in exacerbations
Avoid management (e.g.
Corticosteroid
s) that interfere with diagnosis prior to definitive study (e.g.
Colonoscopy
)
Exclude infection (e.g. C. difficile and other enteric
Bacterial Infection
) pre-diagnosis and with exacerbations
Moderate to severe initial presentation may require hospitalization
Consult general surgery for emergent conditions (e.g.
Toxic Megacolon
, fulminant colitis, bowel perforation, obstruction)
Symptom management in formally diagnosed Inflammatory Bowel Disease (e.g. prior
Colonoscopy
with biopsy)
Avoid starting
Corticosteroid
s unless infection has been excluded, IBD cause is known and GI consultant agrees
Ongoing Inflammatory Bowel Disease management may be adjusted
Patients with increased symptoms on a
Corticosteroid
taper could return to the prior dose
Patients on 5-
Aminosalicylic Acid
could have dosing maximized or add rectal enema (4 g)
Resources
Crohn's and Colitis Foundation of America
http://www.ccfa.org
Cedars-Sinai Inflammatory Bowel Disease Center
http://www.csmc.edu/ibd
References
Cardy and Williams in Swadron (2022) EM:Rap 22(7): 15-7
Kleinmann (2023) Crit Dis Emerg Med 37(2): 22-9
McDowell (2022) Inflammatory Bowel Disease, StatPearls, Treasure Island
https://www.ncbi.nlm.nih.gov/books/NBK470312/
Type your search phrase here